, TABLE cOF cCONTENT
Chapter c1. cThe cRole cof cthe cAdvanced cPractice cNurse cas cPrescriber ............................................................. 4
Chapter c2. cReview cof cBasic cPrinciples cof cPharmacology................................................................................ 5
Chapter c3. cRational cDrug cSelection ................................................................................................................. 11
Chapter c4. cLegal cand cProfessional cIssues cin cPrescribing ............................................................................... 14
Chapter c5. cAdverse cDrug cReactions................................................................................................................. 16
Chapter c6. cAn cIntroduction cto cPharmacogenomics ......................................................................................... 19
Chapter c7. cNutrition cand cNutraceuticals .......................................................................................................... 22
Chapter c8. cHerbal cTherapies ............................................................................................................................. 28
Chapter c9. cCannabis ........................................................................................................................................... 31
Chapter c10. cPharmacoeconomics ....................................................................................................................... 35
Chapter c11. cDrugs cAffecting cthe cAutonomic cNervous cSystem ..................................................................... 38
Chapter c12. cDrugs cAffecting cthe cCentral cNervous cSystem ........................................................................... 45
Chapter c13. cDrugs cAffecting cthe cCardiovascular cand cRenal cSystems .......................................................... 53
Chapter c14. cDrugs cAffecting cthe cRespiratory cSystem .................................................................................... 61
Chapter c15. cDrugs cAffecting cthe cHematological cSystem ............................................................................... 65
Chapter c16. cDrugs cAffecting cthe cImmune cSystem: cVaccines cand cImmunoglobulins .................................. 69
Chapter c17. cDrugs cAffecting cthe cImmune cSystem: cImmunomodulators ....................................................... 75
Chapter c18. cDrugs cAffecting cthe cGastrointestinal cSystem ............................................................................. 77
Chapter c19. cDrugs cAffecting cthe cEndocrine cSystem: cPancreatic cHormones cand cAntidiabetic cDrugs ......... 80
Chapter c20. cDrugs cAffecting cthe cEndocrine cSystem: cPituitary, cThyroid, cand cAdrenal cDrugs ................... 83
Chapter c21. cDrugs cAffecting cthe cReproductive cSystem ................................................................................. 86
Chapter c22. cDrugs cAffecting cthe cBones cand cJoints ....................................................................................... 92
Chapter c23. cDrugs cAffecting cthe cIntegumentary cSystem ............................................................................... 96
Chapter c24. cDrugs cUsed cto cTreat cBacterial cInfections................................................................................. 101
Chapter c25. cDrugs cUsed cto cTreat cViral, cFungal, cand cProtozoal cInfections ............................................... 105
Chapter c26. cDrugs cUsed cto cTreat cInflammatory cProcesses ......................................................................... 108
Chapter c27. cDrugs cUsed cto cTreat cEye cand cEar cDisorders .......................................................................... 111
Chapter c28. cAnemia ......................................................................................................................................... 113
Chapter c29. cAnxiety cand cDepression ............................................................................................................. 116
Chapter c30. cAttention cDeficit-Hyperactivity cDisorder .................................................................................. 120
Chapter c31. cAsthma cand cAllergy ................................................................................................................... 122
Chapter c32. cChronic cObstructive cPulmonary cDisease................................................................................... 125
Chapter c33. cContraception ............................................................................................................................... 127
Chapter c34. cCOVID-19: cAcute cand cChronic ................................................................................................. 130
Chapter c35. cDermatological cConditions ......................................................................................................... 134
Chapter c36. cDiabetes cManagement ................................................................................................................. 138
Chapter c37. cGastroesophageal cReflux cand cPeptic cUlcer cDisease ................................................................ 146
Chapter c38. cHeadaches .................................................................................................................................... 149
Chapter c39. cHeart cFailure ............................................................................................................................... 153
Chapter c40. cHIV cDisease cand cAcquired cImmunodeficiency cSyndrome ...................................................... 158
Chapter c41. cMenopausal cHormone cTherapy .................................................................................................. 161
,Chapter c42. cHyperlipidemia............................................................................................................................. 164
Chapter c43. cHypertension ................................................................................................................................ 169
Chapter c44. cHyperthyroidism cand cHypothyroidism ....................................................................................... 174
Chapter c45. cObesity ......................................................................................................................................... 177
Chapter c46. cPain cManagement: cAcute cand cChronic cPain ............................................................................ 181
Chapter c47. cPneumonia.................................................................................................................................... 185
Chapter c48. cSexually cTransmitted cDiseases cand cVaginitis........................................................................... 187
Chapter c49. cSubstance cUse cDisorders ............................................................................................................ 190
Chapter c50. cTuberculosis ................................................................................................................................. 195
Chapter c51. cUpper cRespiratory cTract cInfection, cPharyngitis, cSinusitis, cOtitis cMedia, cand cOtitis cExterna 197
Chapter c52. cUrinary cTract cInfections ............................................................................................................. 200
Chapter c53. cWomen cas cPatients ..................................................................................................................... 203
Chapter c54. cMen cas cPatients........................................................................................................................... 207
Chapter c55. cPediatric cPatients ......................................................................................................................... 209
Chapter c57. cGeriatric cPatients ......................................................................................................................... 213
, Woo 1
Pharmacotherapeutics cfor cAPN cPrescribers, Ch01
c6e
Chapter c1. cThe cRole cof cthe cAdvanced cPractice cNurse cas cPrescriber
MULTIPLE cCHOICE
1. Nurse cpractitioner cprescriptive cauthority cis cregulated cby:
A. The cNational cCouncil cof cState cBoards cof cNursing
B. The cU.S. cDrug cEnforcement cAdministration
C. The cState cBoard cof cNursing cfor ceach cstate
D. The cState cBoard cof cPharmacy
ANS: c C PTS: c c1
2. The cbenefits cto cthe cpatient cof chaving can cadvanced cpractice cregistered cnurse c(APRN)
cprescriber cinclude:
A. Nurses cknow cmore cabout cpharmacology cthan cother cprescribers cbecause cthey
ctake cit cboth cin ctheir cbasic cnursing cprogram cand cin ctheir cAPRN cprogram.
B. Nurses ccare cfor cthe cpatient cfrom ca cholistic capproach cand cinclude cthe
cpatient cin cdecision-making cregarding ctheir ccare.
C. APRNs care cless clikely cto cprescribe cnarcotics cand cother ccontrolled csubstances.
D. APRNs care cable cto cprescribe cindependently cin call cstates, cwhereas ca
cphysician’s cassistant cneeds cto chave ca cphysician csupervising ctheir
cpractice.
ANS: c B PTS: c c1
3. Clinical cjudgment cin cprescribing cincludes:
A. Factoring cin cthe ccost cto cthe cpatient cof cthe cmedication cprescribed
B. Always cprescribing cthe cnewest cmedication cavailable cfor cthe cdisease cprocess
C. Handing cout cdrug csamples cto cpoor cpatients
D. Prescribing call cgeneric cmedications cto ccut ccosts
ANS: c A PTS: c c1
4. The cprocess cfor cchoosing can ceffective cdrug cfor ca cdisorder cincludes:
A. Asking cthe cpatient cwhat cdrug cthey cthink cwould cwork cbest cfor cthem
B. Consulting cnationally crecognized cguidelines cfor cdisease cmanagement
C. Prescribing cmedications cthat care cavailable cas csamples cbefore cwriting ca cprescription
D. Following cU.S. cDrug cEnforcement cAdministration cguidelines cfor cprescribing
ANS: c B PTS: c c1
5. Nonintentional cnonadherence cof cdrug ctherapy cmay coccur cdue cto:
A. Belief cthat cmedication cdoes cnot cwork
B. Adverse cdrug creactions
C. Chronic cconditions cthat crequire cdaily ctherapy
D. Forgetfulness cor cdistraction
ANS: c D PTS: c c1
Chapter c1. cThe cRole cof cthe cAdvanced cPractice cNurse cas cPrescriber ............................................................. 4
Chapter c2. cReview cof cBasic cPrinciples cof cPharmacology................................................................................ 5
Chapter c3. cRational cDrug cSelection ................................................................................................................. 11
Chapter c4. cLegal cand cProfessional cIssues cin cPrescribing ............................................................................... 14
Chapter c5. cAdverse cDrug cReactions................................................................................................................. 16
Chapter c6. cAn cIntroduction cto cPharmacogenomics ......................................................................................... 19
Chapter c7. cNutrition cand cNutraceuticals .......................................................................................................... 22
Chapter c8. cHerbal cTherapies ............................................................................................................................. 28
Chapter c9. cCannabis ........................................................................................................................................... 31
Chapter c10. cPharmacoeconomics ....................................................................................................................... 35
Chapter c11. cDrugs cAffecting cthe cAutonomic cNervous cSystem ..................................................................... 38
Chapter c12. cDrugs cAffecting cthe cCentral cNervous cSystem ........................................................................... 45
Chapter c13. cDrugs cAffecting cthe cCardiovascular cand cRenal cSystems .......................................................... 53
Chapter c14. cDrugs cAffecting cthe cRespiratory cSystem .................................................................................... 61
Chapter c15. cDrugs cAffecting cthe cHematological cSystem ............................................................................... 65
Chapter c16. cDrugs cAffecting cthe cImmune cSystem: cVaccines cand cImmunoglobulins .................................. 69
Chapter c17. cDrugs cAffecting cthe cImmune cSystem: cImmunomodulators ....................................................... 75
Chapter c18. cDrugs cAffecting cthe cGastrointestinal cSystem ............................................................................. 77
Chapter c19. cDrugs cAffecting cthe cEndocrine cSystem: cPancreatic cHormones cand cAntidiabetic cDrugs ......... 80
Chapter c20. cDrugs cAffecting cthe cEndocrine cSystem: cPituitary, cThyroid, cand cAdrenal cDrugs ................... 83
Chapter c21. cDrugs cAffecting cthe cReproductive cSystem ................................................................................. 86
Chapter c22. cDrugs cAffecting cthe cBones cand cJoints ....................................................................................... 92
Chapter c23. cDrugs cAffecting cthe cIntegumentary cSystem ............................................................................... 96
Chapter c24. cDrugs cUsed cto cTreat cBacterial cInfections................................................................................. 101
Chapter c25. cDrugs cUsed cto cTreat cViral, cFungal, cand cProtozoal cInfections ............................................... 105
Chapter c26. cDrugs cUsed cto cTreat cInflammatory cProcesses ......................................................................... 108
Chapter c27. cDrugs cUsed cto cTreat cEye cand cEar cDisorders .......................................................................... 111
Chapter c28. cAnemia ......................................................................................................................................... 113
Chapter c29. cAnxiety cand cDepression ............................................................................................................. 116
Chapter c30. cAttention cDeficit-Hyperactivity cDisorder .................................................................................. 120
Chapter c31. cAsthma cand cAllergy ................................................................................................................... 122
Chapter c32. cChronic cObstructive cPulmonary cDisease................................................................................... 125
Chapter c33. cContraception ............................................................................................................................... 127
Chapter c34. cCOVID-19: cAcute cand cChronic ................................................................................................. 130
Chapter c35. cDermatological cConditions ......................................................................................................... 134
Chapter c36. cDiabetes cManagement ................................................................................................................. 138
Chapter c37. cGastroesophageal cReflux cand cPeptic cUlcer cDisease ................................................................ 146
Chapter c38. cHeadaches .................................................................................................................................... 149
Chapter c39. cHeart cFailure ............................................................................................................................... 153
Chapter c40. cHIV cDisease cand cAcquired cImmunodeficiency cSyndrome ...................................................... 158
Chapter c41. cMenopausal cHormone cTherapy .................................................................................................. 161
,Chapter c42. cHyperlipidemia............................................................................................................................. 164
Chapter c43. cHypertension ................................................................................................................................ 169
Chapter c44. cHyperthyroidism cand cHypothyroidism ....................................................................................... 174
Chapter c45. cObesity ......................................................................................................................................... 177
Chapter c46. cPain cManagement: cAcute cand cChronic cPain ............................................................................ 181
Chapter c47. cPneumonia.................................................................................................................................... 185
Chapter c48. cSexually cTransmitted cDiseases cand cVaginitis........................................................................... 187
Chapter c49. cSubstance cUse cDisorders ............................................................................................................ 190
Chapter c50. cTuberculosis ................................................................................................................................. 195
Chapter c51. cUpper cRespiratory cTract cInfection, cPharyngitis, cSinusitis, cOtitis cMedia, cand cOtitis cExterna 197
Chapter c52. cUrinary cTract cInfections ............................................................................................................. 200
Chapter c53. cWomen cas cPatients ..................................................................................................................... 203
Chapter c54. cMen cas cPatients........................................................................................................................... 207
Chapter c55. cPediatric cPatients ......................................................................................................................... 209
Chapter c57. cGeriatric cPatients ......................................................................................................................... 213
, Woo 1
Pharmacotherapeutics cfor cAPN cPrescribers, Ch01
c6e
Chapter c1. cThe cRole cof cthe cAdvanced cPractice cNurse cas cPrescriber
MULTIPLE cCHOICE
1. Nurse cpractitioner cprescriptive cauthority cis cregulated cby:
A. The cNational cCouncil cof cState cBoards cof cNursing
B. The cU.S. cDrug cEnforcement cAdministration
C. The cState cBoard cof cNursing cfor ceach cstate
D. The cState cBoard cof cPharmacy
ANS: c C PTS: c c1
2. The cbenefits cto cthe cpatient cof chaving can cadvanced cpractice cregistered cnurse c(APRN)
cprescriber cinclude:
A. Nurses cknow cmore cabout cpharmacology cthan cother cprescribers cbecause cthey
ctake cit cboth cin ctheir cbasic cnursing cprogram cand cin ctheir cAPRN cprogram.
B. Nurses ccare cfor cthe cpatient cfrom ca cholistic capproach cand cinclude cthe
cpatient cin cdecision-making cregarding ctheir ccare.
C. APRNs care cless clikely cto cprescribe cnarcotics cand cother ccontrolled csubstances.
D. APRNs care cable cto cprescribe cindependently cin call cstates, cwhereas ca
cphysician’s cassistant cneeds cto chave ca cphysician csupervising ctheir
cpractice.
ANS: c B PTS: c c1
3. Clinical cjudgment cin cprescribing cincludes:
A. Factoring cin cthe ccost cto cthe cpatient cof cthe cmedication cprescribed
B. Always cprescribing cthe cnewest cmedication cavailable cfor cthe cdisease cprocess
C. Handing cout cdrug csamples cto cpoor cpatients
D. Prescribing call cgeneric cmedications cto ccut ccosts
ANS: c A PTS: c c1
4. The cprocess cfor cchoosing can ceffective cdrug cfor ca cdisorder cincludes:
A. Asking cthe cpatient cwhat cdrug cthey cthink cwould cwork cbest cfor cthem
B. Consulting cnationally crecognized cguidelines cfor cdisease cmanagement
C. Prescribing cmedications cthat care cavailable cas csamples cbefore cwriting ca cprescription
D. Following cU.S. cDrug cEnforcement cAdministration cguidelines cfor cprescribing
ANS: c B PTS: c c1
5. Nonintentional cnonadherence cof cdrug ctherapy cmay coccur cdue cto:
A. Belief cthat cmedication cdoes cnot cwork
B. Adverse cdrug creactions
C. Chronic cconditions cthat crequire cdaily ctherapy
D. Forgetfulness cor cdistraction
ANS: c D PTS: c c1
